Village Farms International
Operates cannabis platforms built from greenhouse cultivation expertise.
Something off on this page? Send us feedback.
Profile
Sells cannabis products in Canada and the Netherlands, plus U.S. CBD consumer products. Its greenhouse-produce roots now support a cannabis-focused structure after most U.S. fresh-produce operations moved to Vanguard.
Runs Pure Sunfarms in Canada, Rose LifeScience in Quebec and Leli in the Netherlands, while Balanced Health supplies U.S. CBD consumer products. These platforms grew from a greenhouse-produce operating base and operate within regulated cannabis markets. It acquired full ownership of Pure Sunfarms following a partner settlement.
Most activity is international, with Canadian cultivation and commercialization complemented by the Netherlands operation. Founder Michael A. DeGiglio remains President and Chief Executive Officer.
Most U.S. fresh-produce assets moved into the Vanguard partnership, while Village Farms retained certain produce and Canadian cultivation assets. Cannabis licenses, market rules and the ongoing Vanguard relationship shape the business.
Company facts
Key statistics
Year to date −21.5% · Average volume (30d) 1.0M
Analysts
Ratings
Target range
Latest analyst notes
No analyst notes in the last 24 months.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026Q2 FY26 | $0.02 | $0.06 | +295.5% | $56.3M | $64.0M | +13.6% | +13.94% |
| May 11, 2026Q1 FY26 | $0.02 | $0.02 | 0.0% | $47.8M | $50.2M | +5.1% | +1.14% |
| Mar 12, 2026Q4 FY25 | $0.05 | $0.02 | −60.0% | $53.0M | $49.6M | −6.4% | −5.90% |
| Nov 10, 2025Q3 FY25 | $0.03 | $0.08 | +166.7% | $60.3M | $66.7M | +10.6% | +4.34% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $77.1M | $59.9M | $66.7M | $49.6M | $50.2M | $64.0M | |
| Gross profit | $11.3M | $22.3M | $31.9M | $19.2M | $21.0M | $30.0M | |
| Operating income | −$5.4M | $6.9M | $16.3M | $4.6M | $5.0M | $11.2M | |
| Net income | −$6.7M | $26.5M | $10.2M | $2.4M | $2.9M | $7.1M | |
| Diluted EPS | −$0.06 | $0.24 | $0.08 | $0.02 | $0.02 | $0.06 | |
| Gross margin | 14.7% | 37.3% | 47.9% | 38.7% | 41.8% | 46.8% | |
| Operating margin | -7.1% | 11.6% | 24.5% | 9.2% | 10.0% | 17.4% |
Fiscal years (4-quarter sums)FY21 $268.0M · FY22 $293.6M · FY23 $285.6M · FY24 $297.6M · FY25 $253.3M
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $72.9M · Total debt $46.2M · Total assets $428.5M · Shareholders' equity $312.2M
Dividends
No dividends on record.
Ownership
Shares outstanding 121.81M · Float 101.51M · 83.3% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Stephen C. Ruffini · director, officer: Chief Financial Officer | 10.25M | 8.42% | Form 4 | Apr 2, 2026 |
| Michael A. Degiglio · director, officer: Chief Executive Officer | 9.70M | 7.96% | Form 4 | Jun 29, 2026 |
| Advisorshares Investments LLC | 5.93M | 4.87% | 13F | Apr 28, 2026 |
| Toroso Investments, LLC | 2.30M | 1.89% | 13F | May 15, 2026 |
| Two Sigma Investments, LP | 1.98M | 1.62% | 13F | May 15, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 26, 2026 | Michael A. Degiglio | director, officer: Chief Executive Officer | +26,400 | $1.89 |
| Jun 29, 2026 | Michael A. Degiglio | director, officer: Chief Executive Officer | +13,600 | $1.87 |
| Mar 25, 2026 | Orville Bovenschen | officer: President of Canadian Cannabis | −50,000 | $2.89 |
| Dec 19, 2025 | Michael A. Degiglio | director, officer: Chief Executive Officer | −118,574 | $4.01 |
| Dec 18, 2025 | Michael A. Degiglio | director, officer: Chief Executive Officer | −200,000 | $4.05 |
Peers
- Tilray Brands
Broad Canadian adult-use and medical cannabis portfolio
- Canopy Growth
Canadian adult-use brands and medical cannabis portfolio
- Organigram Global
Canadian adult-use flower, vapes, edibles and concentrates
- Aurora Cannabis
Canadian consumer and medical cannabis with international reach
- Cronos Group
Canadian adult-use brands plus medical cannabis exports
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Village Farms International | $2.95 | +1.90% | $354.5M | 15.5 | 14.6 | 1.5 | +6.8% |
| Tilray Brands | $4.59 | +0.17% | $513.3M | — | — | 0.4 | +25.5% |
| Canopy Growth | $0.9900 | −1.88% | $421.9M | — | — | 0.8 | +8.4% |
| Organigram Global | $1.20 | −1.99% | $171.0M | 2.7 | 49.6 | 0.7 | +43.3% |
| Aurora Cannabis | $4.01 | +0.25% | $248.4M | — | — | 1.2 | −26.5% |
| Cronos Group | $3.38 | +0.14% | $1.26B | 18.7 | 56.3 | 7.0 | +63.8% |
| Median | 10.7 | 52.9 | 0.8 | +25.5% |








